John Markels

Director, SANGAMO THERAPEUTICS, INC.

Companies

Vaxcyte, Inc.Board member Jul 16, 2026 to now¹
Arcturus TherapeuticsBoard member Dec 13, 2022 to now²
SANGAMO THERAPEUTICS, INCBoard member Feb 13, 2020 to now³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Arcturus Therapeutics ARCT3,131 shares⁴$32.5K at $10.37Jun 14, 2024
SANGAMO THERAPEUTICS, INC SGMOQ96,384 shares⁵$10.6K at $0.11Jun 12, 2025
Vaxcyte, Inc. PCVX0 shares⁶Jul 16, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 12, 2025Granted 25,000 shares of SANGAMO THERAPEUTICS, INC⁵
Jun 14, 2024Exercised options 3,131 shares of Arcturus Therapeutics⁴
Jun 4, 2024Granted 25,000 shares of SANGAMO THERAPEUTICS, INC⁷
Jun 1, 2023Granted 13,900 shares of SANGAMO THERAPEUTICS, INC⁸
Jun 3, 2022Bought 6,784 shares at $3.69 of SANGAMO THERAPEUTICS, INC⁹
Feb 25, 2022Granted 12,500 shares of SANGAMO THERAPEUTICS, INC¹⁰

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARVaxcyte, Inc., Board member
2
SEC EDGARArcturus Therapeutics, Board member
3
SEC EDGARSANGAMO THERAPEUTICS, INC, Board member
4
SEC EDGARArcturus Therapeutics shares after the filing of Jun 14, 2024
5
SEC EDGARSANGAMO THERAPEUTICS, INC shares after the filing of Jun 12, 2025
6
SEC EDGARVaxcyte, Inc. shares after the filing of Jul 16, 2026
7
SEC EDGARForm 4 filed Jun 6, 2024
8
SEC EDGARForm 4 filed Jun 5, 2023
9
SEC EDGARForm 4 filed Jun 6, 2022
10
SEC EDGARForm 4 filed Mar 1, 2022